Cannabis PharmaDrug’s Sairiyo Therapeutics Obtains Approval to Begin Phase 1 Clinical Trial of Patented Reformulated CepharanthineBy Alexander LeeAugust 19, 20240 On August 19, 2024, PharmaDrug Inc. announced that its subsidiary, Sairiyo Therapeutics Inc., has received approval from the Australian Human…
